Eric Lin ’21 

Company / School: LEXEO Therapeutics

Position / Degree: Scientist

Overview

  • BA, Biochemistry, Vassar College

Eric Lin (he/him) is currently a Process Development Scientist at LEXEO Therapeutics, a NYC-based gene therapy company. His work is focused on the upstream manufacturing of AAV vectors to treat cardiac genetic diseases. Eric’s work encompasses the design and execution of small-scale production experiments to improve product titer, productivity, and potency. He is also involved with the volumetric scale up of AAV manufacturing using bioreactors. Prior to his full-time role, Eric joined LEXEO as an intern in June 2022. He ran the first multi-liter AAV production performed entirely at LEXEO’s internal lab. His experiments directly informed the process conditions for manufacturing batches used in subsequent toxicology and pre-clinical studies. Eric received a bachelor’s degree in biochemistry from Vassar. Following matriculation at Vassar, he interned at Novo Nordisk’s New Hampshire biopharmaceutical manufacturing facility as part of the MSAT and QC departments. The following year, Eric received a bachelor of engineering, concentrating in biological/biochemical engineering, through the Dartmouth-Thayer Dual Degree Program.

Advice to Students:

Your first internship experience will open doors and undoubtedly accelerate your career growth and development. Strive to learn as much as you can, take good notes, and offer a helping hand to others.

Comments are closed.

css.php